Periodontitis clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Systemic Valacyclovir (Valtrex) on Periodontitis

    open to eligible people ages 18-80

    The experiment outlined in this proposal is designed to test the hypothesis that herpesvirus suppression by the systemic anti-herpesvirus valacyclovir (Valtrex) can significantly help to arrest the progressive course of severe marginal periodontitis in adult patients. A prospective, randomized, placebo-controlled, double-blind, clinical trial is employed to test this hypothesis.

    San Francisco, California

Our lead scientists for Periodontitis research studies include .

Last updated: